Fifteen-Year Outcomes after Monitoring, Surgery, or Radiotherapy for Prostate Cancer
New England Journal of Medicine · 27.04.2023 · 388 (17) · 1547-1558
DOI: 10.1056/nejmoa2214122 ↗Kurz gefasst
Randomisierte kontrollierte Studie in der Zeitschrift New England Journal of Medicine, erschienen am 27.04.2023. Verfasst von Freddie C Hamdy und 30 weiteren Autor:innen. Beteiligte Einrichtung: From the Nuffield Department of Surgical Sciences, University of Oxford, Oxford (F.C.H., R.J.B., D.E.N.), Population Health Sciences (J.L.D., J.A.L.,…. Hauptthemen laut MEDLINE: Prostate-Specific Antigen, Prostatic Neoplasms. Die Arbeit wurde bisher 838-mal zitiert (Crossref) und nennt 30 Literaturangaben. Gefördert von: Cancer Research UK Integrative Cancer Epidemiology Program, Cancer Research UK, National Institute for Health and Care Research.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- From the Nuffield Department of Surgical Sciences, University of Oxford, Oxford (F.C.H., R.J.B., D.E.N.), Population Health Sciences (J.L.D., J.A.L., C.M., M.D., E.L.T., R.M.M., G.J.Y., E.I.W., T.J.P., N.J.W.) and Brist…
ORCID-Profile: James W F Catto
Förderung
- Cancer Research UK Integrative Cancer Epidemiology Program
- Cancer Research UK
- National Institute for Health and Care Research
- Oxford NIHR Biomedical Research Centre
- Health Technology Assessment Programme
Zitieren
APA
Hamdy, F. C., Donovan, J. L., Lane, J. A., Metcalfe, C., Davis, M., Turner, E. L., Martin, R. M., Young, G. J., Walsh, E. I., Bryant, R. J., Bollina, P., Doble, A., Doherty, A., Gillatt, D., Gnanapragasam, V., Hughes, O., Kockelbergh, R., Kynaston, H., Paul, A., …, & ProtecT Study Group (2023). Fifteen-Year Outcomes after Monitoring, Surgery, or Radiotherapy for Prostate Cancer. New England Journal of Medicine, 388(17), 1547-1558. https://doi.org/10.1056/nejmoa2214122
Vancouver
Hamdy FC, Donovan JL, Lane JA, Metcalfe C, Davis M, Turner EL, et al. Fifteen-Year Outcomes after Monitoring, Surgery, or Radiotherapy for Prostate Cancer. New England Journal of Medicine. 2023;388(17):1547-1558. doi:10.1056/nejmoa2214122
BibTeX
@article{Hamdy2023,
author = {Hamdy, Freddie C and Donovan, Jenny L and Lane, J Athene and Metcalfe, Chris and Davis, Michael and Turner, Emma L and Martin, Richard M and Young, Grace J and Walsh, Eleanor I and Bryant, Richard J and Bollina, Prasad and Doble, Andrew and Doherty, Alan and Gillatt, David and Gnanapragasam, Vincent and Hughes, Owen and Kockelbergh, Roger and Kynaston, Howard and Paul, Alan and Paez, Edgar and Powell, Philip and Rosario, Derek J and Rowe, Edward and Mason, Malcolm and Catto, James W F and Peters, Tim J and Oxley, Jon and Williams, Naomi J and Staffurth, John and Neal, David E and ProtecT Study Group, ProtecT Study Group},
title = {Fifteen-Year Outcomes after Monitoring, Surgery, or Radiotherapy for Prostate Cancer},
journal = {New England Journal of Medicine},
year = {2023},
volume = {388},
number = {17},
pages = {1547--1558},
doi = {10.1056/nejmoa2214122}
}
EUVIMED